darbepoetin

Drugs such as darbepoetin alfa for treating anemic patients on dialysis (in the final stage of kidney disease) were approved in the late 1980s.

PhysOrg.com - latest science and technology news stories 2009

Drugs such as darbepoetin alfa for treating anemic patients on dialysis (in the final stage of kidney disease) were approved in the late 1980s.

THE MEDICAL NEWS 2009

Treatments can include drugs such as darbepoetin alfa, which stimulates the production of new blood cells, although up to one in three patients do not respond to these therapies.

RxPG News : Latest Medical, Healthcare and Research News 2008

Treatments can include drugs such as darbepoetin alfa, which stimulates the production of new blood cells, although up to one in three patients do not respond to these therapies.

Health News from Medical News Today 2008

But FDA reviewers, using the chemical name for Aranesp, said in their posting that the "evidence raises considerable doubt about the safety and advisability of using darbepoetin in this manner."

FDA May Limit Anemia Drug Use For Kidney Disease AP 2010

In fact, in June 2009 we raised the red flag around safety concerns associated with the anemia drugs epoetin alfa (Epogen and Procrit) and darbepoetin alfa (Aranesp) which are both huge-sellers in the U.S.

Reevaluate this: Drugs to boost hemoglobin need better research 2010

As the NEJM authors point out: trials which supported the approval of darbepoetin alfa, and studies of patients with chronic kidney disease showed that those in whom higher hemoglobin concentrations were achieved "may be healthier and therefore more responsive to ESAs."

Reevaluate this: Drugs to boost hemoglobin need better research 2010

As the NEJM authors point out: trials which supported the approval of darbepoetin alfa, and studies of patients with chronic kidney disease showed that those in whom higher hemoglobin concentrations were achieved "may be healthier and therefore more responsive to ESAs."

Reevaluate this: Drugs to boost hemoglobin need better research 2010

In fact, in June 2009 we raised the red flag around safety concerns associated with the anemia drugs epoetin alfa (Epogen and Procrit) and darbepoetin alfa (Aranesp) which are both huge-sellers in the U.S.

Reevaluate this: Drugs to boost hemoglobin need better research 2010

Anemia drugs, known as erythropoiesis-stimulating agents (ESAs), such as epoetin alfa (Epogen) and darbepoetin alfa (Aranesp), stimulate red blood cell production and are intended to reduce the number of blood transfusions required during chemotherapy.

Study: Anemia drugs increase risk of blood clots 2009